{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:17Z","timestamp":1790937137127,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.05.030","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T17:20:28Z","timestamp":1243617628000},"page":"4490-4497","source":"Crossref","is-referenced-by-count":55,"title":["Production of catalytically inactive BoNT\/A1 holoprotein and comparison with BoNT\/A1 subunit vaccines against toxin subtypes A1, A2, and A3"],"prefix":"10.1016","volume":"27","author":[{"given":"Robert P.","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.05.030_bib1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.05.030_bib2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2009.05.030_bib3","series-title":"Botulinum neurotoxin and tetanus toxin","first-page":"53","article-title":"The structure of botulinum neurotoxin","author":"DasGupta","year":"1989"},{"key":"10.1016\/j.vaccine.2009.05.030_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.05.030_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1073\/pnas.0609713104","article-title":"Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept","volume":"104","author":"Rummel","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.030_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03033926","article-title":"Characterization of clostridial botulinum neurotoxin channels in neuroblastoma cells","volume":"9","author":"Fisher","year":"2006","journal-title":"Neurotoxicol Res"},{"key":"10.1016\/j.vaccine.2009.05.030_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.vaccine.2009.05.030_bib8","first-page":"1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.05.030_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.inf.0000256442.06231.17","article-title":"Infant botulism and treatment with BIG-IV (Baby BIG)","volume":"26","author":"Long","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.05.030_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, present and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.05.030_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochemie"},{"key":"10.1016\/j.vaccine.2009.05.030_bib12","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"Smith","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.030_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1\u2013A4","volume":"362","author":"Arndt","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2009.05.030_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among botulinum neurotoxin-producing clostridial strains","volume":"198","author":"Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.05.030_bib15","first-page":"1","article-title":"Analysis of the neurotoxin complex genes in Clostridium botulinum A1\u2013A4 and B1 strains: BoNT\/A3, \/Ba4 and \/B1 clusters are located within plasmids","volume":"12","author":"Smith","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2009.05.030_bib16","first-page":"1","article-title":"Botulinum neurotoxin devoid of receptor binding domain translocates active protease","volume":"4","author":"Fisher","year":"2008","journal-title":"PLoS Pathol"},{"key":"10.1016\/j.vaccine.2009.05.030_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.20008","article-title":"Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain","volume":"19","author":"Chaddock","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.vaccine.2009.05.030_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1359-6446(05)03389-1","article-title":"A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics","volume":"10","author":"Foster","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2009.05.030_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03354881","article-title":"Re-engineering the target specificity of clostridial neurotoxins\u2014a route to novel therapeutics","volume":"9","author":"Foster","year":"2006","journal-title":"Neurotoxicol Res"},{"key":"10.1016\/j.vaccine.2009.05.030_bib20","series-title":"Botulinum toxin therapeutic clinical practice & science","first-page":"349","article-title":"Understanding botulinum neurotoxin mechanism of action and structure to enhance therapeutics and improve care","author":"Foster","year":"2009"},{"key":"10.1016\/j.vaccine.2009.05.030_bib21","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.05.030_bib22","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.030_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants","volume":"41","author":"Jensen","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2009.05.030_bib24","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/bp025516w","article-title":"Design of methanol feed control in Pichia pastoris fermentations based upon a growth model","volume":"6","author":"Zhang","year":"2002","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2009.05.030_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF01886909","article-title":"Proteolysis of synthetic peptides by type A botulinum neurotoxin","volume":"14","author":"Schmidt","year":"1995","journal-title":"J Protein Chem"},{"key":"10.1016\/j.vaccine.2009.05.030_bib26","series-title":"Biomedical aspects of botulism","first-page":"1","article-title":"Structure and structure function relation of botulinum neurotoxins","author":"DasGupta","year":"1981"},{"key":"10.1016\/j.vaccine.2009.05.030_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinum antitoxin","volume":"69","author":"Black","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2009.05.030_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotropic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.05.030_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pep.2005.08.015","article-title":"Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris","volume":"45","author":"Dux","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.05.030_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin serotype F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.05.030_bib31","series-title":"Botulinum toxin therapeutic clinical practice & science","first-page":"374","article-title":"Botulism vaccines and the immune response","author":"Smith","year":"2009"},{"key":"10.1016\/j.vaccine.2009.05.030_bib32","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.65.11.4586-4591.1997","article-title":"Induction of an immune response by oral administration of recombinant botulinum toxin","volume":"65","author":"Kiyatkin","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.030_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/IAI.00843-07","article-title":"Recombinant holotoxoid vaccine against botulism","volume":"76","author":"Pier","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.030_bib34","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.05.030_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-1033.1990.tb15461.x","article-title":"The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene","volume":"189","author":"Thompson","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2009.05.030_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2009.05.030_bib37","doi-asserted-by":"crossref","first-page":"15175","DOI":"10.1021\/bi00046a025","article-title":"Expression and purification of the light chain of botulinum neurotoxin A: a single mutation abolishes its cleavage of SNAP-25 and neurotoxicity after reconstitution with the heavy chain","volume":"34","author":"Zhou","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2009.05.030_bib38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1026549431380","article-title":"Light chain of botulinum A neurotoxin is expressed as an inclusion body from a synthetic gene is catalytically and functionally active","volume":"19","author":"Ahmed","year":"2000","journal-title":"J Protein Chem"},{"key":"10.1016\/j.vaccine.2009.05.030_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbrc.2005.02.123","article-title":"N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B","volume":"330","author":"Jayaraman","year":"2005","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09007051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:46:58Z","timestamp":1589842018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09007051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":39,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09007051"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.05.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}